サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1565643

ライフサイエンスにおける製造実行（MES）システム市場：ソリューションタイプ別、展開別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Manufacturing Execution System in Life Sciences Market, By Solution Type, By Deployment, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ライフサイエンスにおける製造実行（MES）システム市場：ソリューションタイプ別、展開別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年09月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

ライフサイエンスにおける製造実行（MES）システム市場規模は2023年に35億3,043万米ドルとなり、2024年から2032年にかけて12.20%のCAGRで拡大

ライフサイエンスにおける製造実行（MES）システム市場-市場力学

厳しい規制要件

米国のFDA（食品医薬品局）や欧州のEMA（欧州医薬品庁）などの規制機関は、ライフサイエンス製品の安全性と有効性を確保するため、製造プロセスに厳格なガイドラインを課しています。MESシステムは、トレーサビリティ、文書化、監査証跡を提供することで、メーカーがこれらの規制に準拠することを支援します。例えば、FDAの21 CFR Part 11規制では、電子的な記録と署名を安全かつトレーサブルな方法で維持することが義務付けられていますが、MESシステムはこのような規制に対応するのに十分な機能を備えています。法規制への準拠が重視されるようになったことで、MESシステムの導入が進むと予想され、今後5年間で導入率は12%増加すると予測されています。

生産効率と品質管理の向上に対する需要

生産効率と品質管理の向上に対する需要の高まりも、ライフサイエンス分野におけるMES市場の主要な促進要因の1つです。医薬品やバイオテクノロジー製品の複雑さが増すにつれて、メーカーは生産プロセスを管理・最適化するための高度なシステムを必要としています。MESシステムは、生産工程のリアルタイム監視と制御を可能にし、ダウンタイムを削減し、エラーを最小限に抑えます。2023年の調査によると、ライフサイエンスメーカーの65％以上が、MESシステムによって生産効率が大幅に改善され、バッチリリース時間が最大25％短縮されたと回答しています。このような効率化と品質管理の推進は、今後数年間の市場成長を促進すると予想されます。

ライフサイエンスにおける製造実行（MES）システム市場-主要インサイト

リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約12.20%のCAGRで毎年成長すると予測されています。

ソリューションタイプのセグメンテーションに基づくと、2023年にはソフトウェアが最大の市場シェアを示すと予測されました。

展開別では、クラウドベースのデプロイメントが2023年の主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

ライフサイエンスにおける製造実行（MES）システム市場-セグメンテーション分析：

ライフサイエンスにおける製造実行（MES）システムの世界市場は、ソリューションタイプ、展開、エンドユーザー、地域に基づいてセグメント化されます。

市場はソリューションタイプに基づいて4つのカテゴリーに分けられる：ソフトウェアとサービス。ソフトウェア分野は、ライフサイエンス市場のセグメンテーションにおいて重要な要素であり、複雑な製造プロセスを処理し、規制コンプライアンスを確保できる高度なソリューションへのニーズが原動力となっています。このセグメントの主な原動力は、リアルタイムデータ分析、予知保全、ERP（統合基幹業務システム）やQMS（品質管理システム）といった他の企業システムとの統合といった機能を含む、ソフトウェア機能の継続的な進化です。これらの機能は、メーカーが生産を最適化し、運用コストを削減し、製品品質を確保するのに役立ちます。

市場は、展開形態によって2つのカテゴリーに分けられる：オンプレミス型、クラウド型、ハイブリッド型です。クラウドベースのMESソリューションは、従来のオンプレミスシステムに比べて、初期コストの削減、拡張性、他のクラウドベースのアプリケーションとの統合の容易さなど、いくつかの利点があります。MESシステムへのリモートアクセスが可能で、データセキュリティやコンプライアンス機能も強化されているため、ライフサイエンスメーカーにとってクラウドベースのソリューションは特に魅力的です。

ライフサイエンスにおける製造実行（MES）システム市場-地理的洞察

アジア太平洋地域は、中国、インド、日本などの国々における製薬・バイオテクノロジー産業の急速な拡大に牽引され、ライフサイエンス分野のMES市場にとって重要な成長地域として浮上しています。同地域では、現地生産能力を高めるための政府の取り組みと相まって、製造プロセスの改善に注力する傾向が強まっており、先進的なMESソリューションの需要に拍車をかけています。さらに、同地域では製造受託機関（CMO）の増加やジェネリック医薬品生産の増加がMES市場の成長に寄与しています。

ライフサイエンスにおける製造実行（MES）システム市場-競合情勢：

ライフサイエンス業界における世界のMES市場は競争が激しく、複数の主要企業が市場を独占しています。主な業界プレイヤーには、Siemens AG、Rockwell Automation、Honeywell International Inc.、Werum IT Solutions GmbH（a Korber AG company）、Emerson Electric Co.これらの企業は、市場での地位を強化するため、技術革新、戦略的パートナーシップ、買収に注力しています。例えば、シーメンスAGは戦略的買収や主要ライフサイエンス企業との提携を通じてMESポートフォリオを拡大しており、ロックウェル・オートメーションはインテリジェントな製造システムに対する需要の高まりに対応するため、AIを活用したソリューションでMES機能を強化しています。競合情勢の特徴は、継続的な技術の進歩と、ライフサイエンス業界の進化するニーズに対応するために設計された新しいソフトウェアソリューションの導入です。

目次

第1章 ライフサイエンス市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ライフサイエンスにおける製造実行（MES）システムの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ライフサイエンスにおける製造実行（MES）システムの産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ライフサイエンスにおける製造実行（MES）システム市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ライフサイエンス市場情勢における製造実行システム

  • ライフサイエンスにおける製造実行システムの市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ライフサイエンスにおける製造実行（MES）システム市場- ソリューションタイプ別

  • 概要
    • セグメントシェア分析
    • ソフトウェア
    • サービス

第8章 ライフサイエンスにおける製造実行（MES）システム市場- 展開別

  • 概要
    • セグメントシェア分析
    • オンプレミス
    • クラウド/Webベース
    • ハイブリッド

第9章 ライフサイエンスにおける製造実行（MES）システム市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 製薬・バイオテクノロジー企業
    • 医療機器企業
    • その他

第10章 ライフサイエンスにおける製造実行（MES）システム市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ライフサイエンスにおける製造実行（MES）システム産業

  • 競争ダッシュボード
  • 企業プロファイル
    • ABB
    • Korber AG
    • MasterControl Solutions, Inc.
    • AVEVA Group Limited
    • Cognizant
    • Rockwell Automation
    • Siemens AG
    • Emerson Electric Co.
    • iBase-t
    • Nagarro

第12章 アナリストの全方位展望

目次
Product Code: ANV3849

REPORT HIGHLIGHT

Manufacturing Execution System in Life Sciences Market size was valued at USD 3,530.43 Million in 2023, expanding at a CAGR of 12.20% from 2024 to 2032.

The Manufacturing Execution System (MES) in the life sciences market refers to specialized software solutions designed to manage and monitor production processes in industries such as pharmaceuticals, biotechnology, and medical devices. MES systems in life sciences are crucial for ensuring compliance with stringent regulatory requirements, improving production efficiency, and maintaining high-quality standards throughout the manufacturing process. These systems provide real-time data collection, monitoring, and control, enabling manufacturers to optimize production workflows, reduce waste, and enhance overall productivity.

Manufacturing Execution System in Life Sciences Market- Market Dynamics

Stringent Regulatory Requirements

Regulatory bodies such as the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe impose strict guidelines on manufacturing processes to ensure the safety and efficacy of life sciences products. MES systems help manufacturers comply with these regulations by providing traceability, documentation, and audit trails. For instance, the FDA's 21 CFR Part 11 regulation requires electronic records and signatures to be maintained in a secure and traceable manner, which MES systems are well-equipped to handle. The growing emphasis on regulatory compliance is expected to drive the adoption of MES systems, with a forecasted 12% increase in adoption rates in the next five years.

Demand for Improved Production Efficiency and Quality Control

The increasing demand for improved production efficiency and quality control is another key driver of the MES market in life sciences. As the complexity of pharmaceutical and biotechnological products increases, manufacturers require advanced systems to manage and optimize their production processes. MES systems enable real-time monitoring and control of production, reducing downtime and minimizing errors. According to a 2023 survey, over 65% of life sciences manufacturers reported that MES systems significantly improved their production efficiency and reduced batch release times by up to 25%. This drive towards efficiency and quality control is expected to fuel market growth in the coming years.

Manufacturing Execution System in Life Sciences Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.20% over the forecast period (2024-2032)

Based on Solution Type segmentation, Software was predicted to show maximum market share in the year 2023

Based on Deployment segmentation, Cloud-Based deployment was the leading type in 2023

On the basis of Region, North America was the leading revenue generator in 2023

Manufacturing Execution System in Life Sciences Market- Segmentation Analysis:

The Global Manufacturing Execution System in Life Sciences Market is segmented on the basis of Solution Type, Deployment, End-user, and Region.

The market is divided into four categories based on Solution Type: Software and Services. The software segment is a critical component of the MES in the life sciences market, driven by the need for advanced solutions that can handle complex manufacturing processes and ensure regulatory compliance. The primary driver for this segment is the continuous evolution of software capabilities, including features such as real-time data analytics, predictive maintenance, and integration with other enterprise systems like ERP (Enterprise Resource Planning) and QMS (Quality Management System). These features help manufacturers optimize production, reduce operational costs, and ensure product quality.

The market is divided into two categories based on Deployment: On-Premise, Cloud-Based and Hybrid. Cloud-based MES solutions offer several advantages over traditional on-premises systems, including lower upfront costs, scalability, and easier integration with other cloud-based applications. The ability to access MES systems remotely, coupled with enhanced data security and compliance features, makes cloud-based solutions particularly attractive for life sciences manufacturers.

Manufacturing Execution System in Life Sciences Market- Geographical Insights

The Asia Pacific region is emerging as a key growth area for the MES in the life sciences market, driven by the rapid expansion of the pharmaceutical and biotechnology industries in countries like China, India, and Japan. The region's growing focus on improving manufacturing processes, coupled with government initiatives to boost local production capabilities, is fueling the demand for advanced MES solutions. Additionally, the increasing number of contract manufacturing organizations (CMOs) and the rise in generic drug production in the region are contributing to the growth of the MES market.

Manufacturing Execution System in Life Sciences Market- Competitive Landscape:

The global MES market in the life sciences industry is highly competitive, with several key players dominating the market. Major industry players include Siemens AG, Rockwell Automation, Honeywell International Inc., Werum IT Solutions GmbH (a Korber AG company), and Emerson Electric Co. These companies are focusing on innovation, strategic partnerships, and acquisitions to strengthen their market position. For instance, Siemens AG has been expanding its MES portfolio through strategic acquisitions and partnerships with leading life sciences companies, while Rockwell Automation is enhancing its MES capabilities with AI-driven solutions to cater to the growing demand for intelligent manufacturing systems. The competitive landscape is characterized by continuous technological advancements and the introduction of new software solutions designed to meet the evolving needs of the life sciences industry.

Recent Developments:

In May 2024, Korber Pharma and Siemens Take the Lead in ABI Research's MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive Ranking.

In January 2024, Rockwell Automation, Inc., the world's largest company dedicated to industrial automation and digital transformation, today announced that as part of an ongoing company-wide digitalization program, Rottendorf Pharma GmbH is introducing the FactoryTalk PharmaSuite(R) manufacturing execution system from Rockwell Automation, a comprehensive electronic batch recording solution.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • ABB
  • Korber AG
  • MasterControl Solutions, Inc.
  • AVEVA Group Limited
  • Cognizant
  • Rockwell Automation
  • Siemens AG
  • Emerson Electric Co.
  • iBase-t
  • Nagarro

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET, BY SOLUTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET, BY DEPLOYMENT- MARKET ANALYSIS, 2019 - 2032

  • On-Premise
  • Cloud-Based
  • Hybrid

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Medical Devices Companies
  • Others

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Manufacturing Execution System in Life Sciences Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Manufacturing Execution System in Life Sciences Market Snippet by Solution Type
    • 2.1.2. Manufacturing Execution System in Life Sciences Market Snippet by Deployment
    • 2.1.3. Manufacturing Execution System in Life Sciences Market Snippet by End-user
    • 2.1.4. Manufacturing Execution System in Life Sciences Market Snippet by Country
    • 2.1.5. Manufacturing Execution System in Life Sciences Market Snippet by Region
  • 2.2. Competitive Insights

3. Manufacturing Execution System in Life Sciences Key Market Trends

  • 3.1. Manufacturing Execution System in Life Sciences Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Manufacturing Execution System in Life Sciences Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Manufacturing Execution System in Life Sciences Market Opportunities
  • 3.4. Manufacturing Execution System in Life Sciences Market Future Trends

4. Manufacturing Execution System in Life Sciences Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Manufacturing Execution System in Life Sciences Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Manufacturing Execution System in Life Sciences Market Landscape

  • 6.1. Manufacturing Execution System in Life Sciences Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Manufacturing Execution System in Life Sciences Market - By Solution Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Solution Type, 2023 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services

8. Manufacturing Execution System in Life Sciences Market - By Deployment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment, 2023 & 2032 (%)
    • 8.1.2. On-Premise
    • 8.1.3. Cloud/Web-Based
    • 8.1.4. Hybrid

9. Manufacturing Execution System in Life Sciences Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
    • 9.1.2. Pharmaceutical & Biotechnology Companies
    • 9.1.3. Medical Device Companies
    • 9.1.4. Others

10. Manufacturing Execution System in Life Sciences Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Manufacturing Execution System in Life Sciences Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Manufacturing Execution System in Life Sciences Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Manufacturing Execution System in Life Sciences Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Manufacturing Execution System in Life Sciences Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Manufacturing Execution System in Life Sciences Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Manufacturing Execution System in Life Sciences Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. ABB
    • 11.2.2. Korber AG
    • 11.2.3. MasterControl Solutions, Inc.
    • 11.2.4. AVEVA Group Limited
    • 11.2.5. Cognizant
    • 11.2.6. Rockwell Automation
    • 11.2.7. Siemens AG
    • 11.2.8. Emerson Electric Co.
    • 11.2.9. iBase-t
    • 11.2.10. Nagarro

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us